336 related articles for article (PubMed ID: 34122421)
1. Connective Tissue Growth Factor Is Overexpressed in Explant Lung Tissue and Broncho-Alveolar Lavage in Transplant-Related Pulmonary Fibrosis.
Vanstapel A; Goldschmeding R; Broekhuizen R; Nguyen T; Sacreas A; Kaes J; Heigl T; Verleden SE; De Zutter A; Verleden G; Weynand B; Verbeken E; Ceulemans LJ; Van Raemdonck DE; Neyrinck AP; Schoemans HM; Vanaudenaerde BM; Vos R
Front Immunol; 2021; 12():661761. PubMed ID: 34122421
[TBL] [Abstract][Full Text] [Related]
2. Pulmonary epithelial markers in phenotypes of chronic lung allograft dysfunction.
Levy L; Moshkelgosha S; Huszti E; Hunter S; Renaud-Picard B; Berra G; Kawashima M; Fernandez-Castillo J; Fuchs E; Dianti M; Ghany R; Keshavjee S; Singer LG; Tikkanen J; Martinu T
J Heart Lung Transplant; 2023 Aug; 42(8):1152-1160. PubMed ID: 36963446
[TBL] [Abstract][Full Text] [Related]
3. The common rejection module in chronic rejection post lung transplantation.
Sacreas A; Yang JYC; Vanaudenaerde BM; Sigdel TK; Liberto JM; Damm I; Verleden GM; Vos R; Verleden SE; Sarwal MM
PLoS One; 2018; 13(10):e0205107. PubMed ID: 30289917
[TBL] [Abstract][Full Text] [Related]
4. Distinct expression patterns of alveolar "alarmins" in subtypes of chronic lung allograft dysfunction.
Saito T; Liu M; Binnie M; Sato M; Hwang D; Azad S; Machuca TN; Zamel R; Waddell TK; Cypel M; Keshavjee S
Am J Transplant; 2014 Jun; 14(6):1425-32. PubMed ID: 24787265
[TBL] [Abstract][Full Text] [Related]
5. Humoral immunity in phenotypes of chronic lung allograft dysfunction: A broncho-alveolar lavage fluid analysis.
Vandermeulen E; Verleden SE; Bellon H; Ruttens D; Lammertyn E; Claes S; Vandooren J; Ugarte-Berzal E; Schols D; Emonds MP; Van Raemdonck DE; Opdenakker G; Verleden GM; Vos R; Vanaudenaerde BM
Transpl Immunol; 2016 Sep; 38():27-32. PubMed ID: 27561239
[TBL] [Abstract][Full Text] [Related]
6. Epithelial cell death markers in bronchoalveolar lavage correlate with chronic lung allograft dysfunction subtypes and survival in lung transplant recipients-a single-center retrospective cohort study.
Levy L; Tigert A; Huszti E; Saito T; Mitsakakis N; Moshkelgosha S; Joe B; Boonstra KM; Tikkanen JM; Keshavjee S; Juvet SC; Martinu T
Transpl Int; 2019 Sep; 32(9):965-973. PubMed ID: 31002407
[TBL] [Abstract][Full Text] [Related]
7. Restrictive allograft syndrome (RAS): a novel form of chronic lung allograft dysfunction.
Sato M; Waddell TK; Wagnetz U; Roberts HC; Hwang DM; Haroon A; Wagnetz D; Chaparro C; Singer LG; Hutcheon MA; Keshavjee S
J Heart Lung Transplant; 2011 Jul; 30(7):735-42. PubMed ID: 21419659
[TBL] [Abstract][Full Text] [Related]
8. Validation of a post-transplant chronic lung allograft dysfunction classification system.
Van Herck A; Verleden SE; Sacreas A; Heigl T; Vanaudenaerde BM; Dupont LJ; Yserbyt J; Verbeken EK; Neyrinck AP; Van Raemdonck D; Verleden GM; Vos R
J Heart Lung Transplant; 2019 Feb; 38(2):166-173. PubMed ID: 30391199
[TBL] [Abstract][Full Text] [Related]
9. BALF cytokines in different phenotypes of chronic lung allograft dysfunction in lung transplant patients.
Berastegui C; Gómez-Ollés S; Sánchez-Vidaurre S; Culebras M; Monforte V; López-Meseguer M; Bravo C; Ramon MA; Romero L; Sole J; Cruz MJ; Román A
Clin Transplant; 2017 Mar; 31(3):. PubMed ID: 28008659
[TBL] [Abstract][Full Text] [Related]
10. Low-dose computed tomography volumetry for subtyping chronic lung allograft dysfunction.
Saito T; Horie M; Sato M; Nakajima D; Shoushtarizadeh H; Binnie M; Azad S; Hwang DM; Machuca TN; Waddell TK; Singer LG; Cypel M; Liu M; Paul NS; Keshavjee S
J Heart Lung Transplant; 2016 Jan; 35(1):59-66. PubMed ID: 26342441
[TBL] [Abstract][Full Text] [Related]
11. The Lymphatic Phenotype of Lung Allografts in Patients With Bronchiolitis Obliterans Syndrome and Restrictive Allograft Syndrome.
Traxler D; Schweiger T; Schwarz S; Schuster MM; Jaksch P; Lang G; Birner P; Klepetko W; Ankersmit HJ; Hoetzenecker K
Transplantation; 2017 Feb; 101(2):310-315. PubMed ID: 27163544
[TBL] [Abstract][Full Text] [Related]
12. The pleural mesothelium and transforming growth factor-β
Sacreas A; von der Thüsen JH; van den Bosch TPP; Weynand B; Verbeken EK; Debbaut C; Van Raemdonck DE; Vos R; Verleden SE
J Heart Lung Transplant; 2019 May; 38(5):570-579. PubMed ID: 30819647
[TBL] [Abstract][Full Text] [Related]
13. The autotaxin-lysophosphatidic acid pathway mediates mesenchymal cell recruitment and fibrotic contraction in lung transplant fibrosis.
Sinclair KA; Yerkovich ST; Hopkins PM; Fieuw AM; Ford P; Powell JE; O'Sullivan B; Chambers DC
J Heart Lung Transplant; 2021 Jan; 40(1):12-23. PubMed ID: 33339555
[TBL] [Abstract][Full Text] [Related]
14. Characterization of chronic lung allograft dysfunction phenotypes using spectral and intrabreath oscillometry.
Fu A; Vasileva A; Hanafi N; Belousova N; Wu J; Rajyam SS; Ryan CM; Hantos Z; Chow CW
Front Physiol; 2022; 13():980942. PubMed ID: 36277208
[No Abstract] [Full Text] [Related]
15. Immunological diversity in phenotypes of chronic lung allograft dysfunction: a comprehensive immunohistochemical analysis.
Vandermeulen E; Lammertyn E; Verleden SE; Ruttens D; Bellon H; Ricciardi M; Somers J; Bracke KR; Van Den Eynde K; Tousseyn T; Brusselle GG; Verbeken EK; Verschakelen J; Emonds MP; Van Raemdonck DE; Verleden GM; Vos R; Vanaudenaerde BM
Transpl Int; 2017 Feb; 30(2):134-143. PubMed ID: 27933655
[TBL] [Abstract][Full Text] [Related]
16. MiR-21 in Lung Transplant Recipients With Chronic Lung Allograft Dysfunction.
Miyahara N; Benazzo A; Oberndorfer F; Iwasaki A; Laszlo V; Döme B; Hoda MA; Jaksch P; Klepetko W; Hoetzenecker K
Transpl Int; 2021; 35():10184. PubMed ID: 35185369
[No Abstract] [Full Text] [Related]
17. Fibroproliferation in chronic lung allograft dysfunction: Association of mesenchymal cells in bronchoalveolar lavage with phenotypes and survival.
Combs MP; Xia M; Wheeler DS; Belloli EA; Walker NM; Braeuer RR; Lyu DM; Murray S; Lama VN
J Heart Lung Transplant; 2020 Aug; 39(8):815-823. PubMed ID: 32360292
[TBL] [Abstract][Full Text] [Related]
18. Bronchiolitis obliterans syndrome and restrictive allograft syndrome: do risk factors differ?
Verleden SE; Ruttens D; Vandermeulen E; Vaneylen A; Dupont LJ; Van Raemdonck DE; Verleden GM; Vanaudenaerde BM; Vos R
Transplantation; 2013 May; 95(9):1167-72. PubMed ID: 23425818
[TBL] [Abstract][Full Text] [Related]
19. Bronchoalveolar lavage cytokine-based risk stratification of minimal acute rejection in clinically stable lung transplant recipients.
Levy L; Huszti E; Ahmed M; Ghany R; Hunter S; Moshkelgosha S; Zhang CYK; Boonstra K; Klement W; Tikkanen J; Singer LG; Keshavjee S; Juvet S; Martinu T
J Heart Lung Transplant; 2021 Dec; 40(12):1540-1549. PubMed ID: 34215500
[TBL] [Abstract][Full Text] [Related]
20. Mechanistic differences between phenotypes of chronic lung allograft dysfunction after lung transplantation.
Suwara MI; Vanaudenaerde BM; Verleden SE; Vos R; Green NJ; Ward C; Borthwick LA; Vandermeulen E; Lordan J; Van Raemdonck DE; Corris PA; Verleden GM; Fisher AJ
Transpl Int; 2014 Aug; 27(8):857-67. PubMed ID: 24750386
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]